Early detection of relapse by prospective reverse transcriptase- polymerase chain reaction analysis of the PML/RARα fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter 'AIDA' trial

Blood

Volumn 92, Issue 3, 1998, Pages 784-789

  Diverio, Daniela ^b   Rossi, Vincenzo ^b   Avvisati, Giuseppe ^b   De Santis, Silvia ^b   Pistilli, Alessandra ^b   Pane, Fabrizio ^b   Saglio, Giuseppe ^b   Martinelli, Giovanni ^b   Petti, Maria Concerta ^b   Santoro, Alessandra ^b   Pelicci, Pier Giuseppe ^b   Mandelli, Franco ^b   Biondi, Andrea ^b   Coco, Francesco Lo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CLINICAL TRIAL; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RECURRENT CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032147033     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.3.784     Document Type: Article

References (28)

1. Avvisati G, ten Cate JW, Mandelli F: Acute promyelocytic leukemia. Br J Haematol 81:315, 1993
2. Wiernik PH, Gallagher RE, Tallman MS: Diagnosis and treatment of acute promyelocytic leukemia, in Wiernik PH, Canellos GP, Dutcher JP, Kyle RA (eds): Neoplastic Diseases of the Blood (ed 3). New York, NY, Churchill Livingstone, 1996, p 353
3. Frankel SR, Eardley A, Heller G, Herman E, Miller WH Jr, Dmitrovsky E, Warrell RP Jr: All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York study. Ann Intern Med 120:1722, 1995
4. Kanamuru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, Hiraoka A, Yamada O, Oh H, Saito K, Matsuda S, Minato K, Ohno R and the Japan Adult Leukemia Study Group: All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 85:1202, 1995
5. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Ceeri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Willemze R, Muus P, Pelicci PG, Biondi A, Lo Coco F: Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood 90:1014, 1997
6. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman CL, Bloomfield CD, Rowe JM, Wiernik PH: All-trans retinoic acid in acute promyelocytic leukemia. N Engl J Med 337:1201, 1997
7. Fenaux P, Chastang C, Sanz MA, Thomas X, Dombret H, Link H, Guerci A, Fegueux N, San Miguel J, Rayon C, Zittoun R, Gardin C, Maloisel F, Fey M, Travade P, Reiffers J, Stamatoulas A, Stoppa AM, Caillot D, Lefrére F, Hayat M, Castaigne S, Chomienne C, Degos L: ATRA followed by chemotherapy (CT) vs ATRA plus CT and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia (APL): First interim results of APL93 trial. Blood 90:533a, 1997 (suppl l,abstr)
8. Burnett AK, Goldstone AH, Gray RG, Wheatley K on behalf of the UK MRC Adult Leukemia Working Party: All Irans retinoic acid given concurrently with induction chemotherapy improves the outcome of APL: Results of the UK MRC ATRA trial. Blood 90:1474a, 1997 (suppl 1, abstr)
9. Tobita T, Takeshita A, Kitamura K, Ohnishi K, Yanagi M, Hiraoka A, Karasuno T. Takeuchi M, Miyawaki S, Ueda R, Naoe T, Ohno R: Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood 90:967, 1997
10. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89:3354, 1997
11. Miller WH Jr, Kakizuka A, Frankel SR, Warrell RP Jr, De Blasio A, Levine K, Eans RM, Dmitrovsky E: Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor a clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci USA 89:2694, 1992
12. Biondi A, Rambaldi A, Pandolfi PP, Rossi V, Giudici G, Alcalay M, Lo Coco F, Diverio D, Pogliani EM, Lanzi EM, Mandelli F, Masera G, Barbui T, Pelicci PG: Molecular monitoring of the myl/RARa fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 80:49, 1992
13. Lo Coco F, Diverio D, Pandolfi PP, Biondi A, Rossi V, Avvisati G, Rambaldi A, Arcese W, Petti MC, Meloni G, Mandelli F, Grignani F, Masera G, Barbui T, Pelicci PG: Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancet 340:1437, 1992
14. Chang KS, Lu J, Wang G, Trujillo JM, Estey E, Cork A, Chu DT, Freireich EJ, Stass SA: The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene. Targets for the detection of minimal residual disease by polymerase chain reaction. Blood 79:54, 1992
15. Huang W, Sun G-L, Li X-S, Cao Q, Lu Y, Jang G-S, Zhang F-Q, Chai J-R, Wang Z-Y, Waxman S, Chen Z, Chen S-J: Acute promyelocytic leukemia: Relevance of two major PML-RARa isoforms and detection of minimal residual disease by retrotranscriptase-polymerase chain reaction. Blood 82:1264, 1993
16. Miller WH Jr, Levine K, De Blasio A, Frankel SR, Dmitrovsky E, Warrell RP Jr: Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction. Blood 82:1689, 1993
17. Diverio D, Pandolfi PP, Biondi A, Avvisati G, Petti MC, Mandelli F, Pelicci PG, Lo Coco F: Absence of RT-PCR detectable residual disease in acute promyelocytic leukemia in long-term remission. Blood 85:3556, 1993
18. Korninger L, Knobl P, Laczika K, Mustafa S, Quehenberger P, Schwarzinger I, Lechner K, Jaeger U, Mannhalter C: PML/RARα PCR positivity in the bone marrow of patients with APL precedes haematological relapse by 2-3 months. Br J Haematol 88:427, 1994
19. Fukutani H, Naoe T, Ohno R, Yoshida H, Kiyoi H, Miyawaki S, Morishita H, Sano F, Kamibayashi H, Matsue K, Miyake T, Hasegawa S, Ueda Y, Kato Y, Kobayashi H, Shimazaki C, Kobayashi M, Kurane R, Sakota H, Masaki K, Wakayama T, Tohyama K, Nonaka Y, Natori H: Prognostic significance of the RT-PCR assay of PML/RARα transcripts in acute promyelocytic leukemia. Leukemia 9:588. 1995
20. Grimwade D, Howe K, Langabeer S, Burnett AK, Goldstone A, Solomon E: Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: Evaluation of PML-RARα and RARα-PML assessment in patients who ultimately relapse. Leukemia 10:61, 1996
21. Roman J, Martin C, Torres A, Jimenez MA, Andres O, Flores R, De la Torre MJ, Sanchez J, Serrano J, Falcon M: Absence of detectable PML/RARα fusion transcripts in long-term remission patients after bone marrow transplantation for acute promyelocytic leukemia. Bone Marrow Transplant 17:679, 1997
22. Chomczynsky P, Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate-phenol chloroform extraction. Anal Biochem 162:278, 1987
23. Avvisati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M, Russo M, Petti MC, Mandelli F: AIDA (All-trans retinoic acid + Idarubicin) in newly diagnosed acute promyelocytic leukemia: A Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) pilot study. Blood 88:1390, 1996
24. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
25. Cox DR: Regression models and life tables. J R Stat Soc B: 34:187, 1972
26. Campana D, Pui C-H: Detection of minimal residual disease in acute leukemia: Methodological advances and clinical significance. Blood 85:1416, 1995
27. Scale JRC, Varma S, Swirsky DM, Pandolfi PP, Goldman JM, Cross NCP: Quantification of PML/RARα transcripts in acute promyelocytic leukemia: Explanation for lack of sensitivity of RT-PCR for the detection of minimal residual disease and induction of the leukemiaspecific mRNA by alpha Interferon. Br J Haematol 95:95, 1996
28. Diverio D. Riccioni R, Mandelli F, Lo Coco F: The PML/RARα fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia. Haematologica 80:155, 1995